SOURCE-LINKED STUDY SUMMARY
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Abstract summarizedQuality not appraised
- What was studied
- A randomized controlled trial examined nandrolone’s anabolic effects in patients receiving dialysis.
- Who / model studied
- Adults receiving chronic dialysis were studied with body-composition, functional and quality-of-life outcomes.
- Studied dose & schedule
- Nandrolone decanoate 100 mg weekly or placebo for 6 months, alongside usual dialysis care.
- What the study found
- The study assessed whether nandrolone increased lean body mass and improved strength, walking, stair-climbing or related function compared with placebo.
- Limitations & context
- Dialysis patients have a distinct disease burden and treatment context. The trial was not designed to establish long-term safety or effects in healthy people.
Read summary source ↗ · Prepared 9/25/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1001/jama.281.14.1275